Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
JAMA|July 14, 2004
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trialJoel E Gallant, Schlomo Staszewski, Anton L Pozniak, et al.HIV Medicine|March 14, 2007
Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2, Zoe Fox, Francisco Antunes, et al.Archives of Internal Medicine|March 15, 2006
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002Fiona C Lampe, Jose M Gatell, Schlomo Staszewski, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settingsHartmut Stocker, Charlotte Kloft, Nele Plock, et al.Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North AmericaEnrico Girardi, Caroline A Sabin, Antonella d'Arminio Monforte, et al.Lancet (London, England)|August 8, 2006
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysisMargaret T May, Jonathan A C Sterne, Dominique Costagliola, et al.Lancet (London, England)|July 6, 2004
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesBruno Ledergerber, Jens D Lundgren, A Sarah Walker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2009
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal, Amanda Mocroft, Jonathan A C Sterne, et al.Journal of Virology|November 5, 2010
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive diseaseJulian Schulze Zur Wiesch, Adriana Thomssen, Philip Hartjen, et al.Pageof 7